Lombard Odier Asset Management (Switzerland)’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-168,795
| Closed | -$2.43M | – | 373 |
|
|
2022
Q3 | $2.43M | Sell |
168,795
-12,138
| -7% | -$175K | 0.21% | 103 |
|
|
2022
Q2 | $2.74M | Sell |
180,933
-40,841
| -18% | -$618K | 0.23% | 97 |
|
|
2022
Q1 | $2.64M | Sell |
221,774
-163,666
| -42% | -$1.94M | 0.21% | 80 |
|
|
2021
Q4 | $6.25M | Buy |
385,440
+32,601
| +9% | +$528K | 0.4% | 61 |
|
|
2021
Q3 | $10.1M | Buy |
352,839
+32,807
| +10% | +$936K | 0.63% | 61 |
|
|
2021
Q2 | $10.8M | Buy |
320,032
+138,540
| +76% | +$4.68M | 0.55% | 66 |
|
|
2021
Q1 | $5.49M | Buy |
+181,492
| New | +$5.49M | 0.36% | 75 |
|